Biorep Technologies

Executive Summary

Biorep Technologies, a US-based CDMO founded in 1999, provides end-to-end medical device development and manufacturing services under ISO 13485 certification. Headquartered in Miami, the company supports med-tech innovators from prototyping and design verification through full-scale contract manufacturing and assembly. By offering a single-source solution, Biorep helps clients accelerate time-to-market and reduce regulatory risks, positioning itself as a trusted partner for bringing complex medical devices to regulated markets. With over two decades of operational experience, Biorep has established a niche in the medical device CDMO space. The growing demand for outsourced manufacturing, driven by cost pressures and regulatory complexities, presents a tailwind for the company. While privately held and limited in public disclosures, Biorep's long track record and specialization suggest stable operations. Future growth will likely depend on capacity expansion, strategic partnerships, and broadening of certifications to serve global clients.

Upcoming Catalysts (preview)

• Q4 2026Expansion of manufacturing capacity to meet rising demand for medical device outsourcing65% success
• Q3 2026Securing a multi-year contract with a leading diagnostics or med-tech company40% success
• Q1 2027Obtaining MDSAP certification to streamline international regulatory approvals75% success